Kura oncology, inc. (KURA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating Activities
Net loss

-68,410

-63,140

-61,372

-59,987

-59,783

-60,447

-55,098

-49,424

-42,505

-35,434

-32,033

-29,626

-28,467

-27,560

-26,687

-25,851

-24,775

-22,625

-19,822

-13,738

-8,160

-3,690

-28

-28

-28

-28

-28

-28

-27

-27

-26

-26

-27

-27

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense

10,293

9,409

8,686

8,757

8,744

8,654

8,384

7,036

5,830

4,545

3,685

3,094

2,493

2,089

2,099

2,049

2,105

2,259

1,900

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

184

223

200

159

118

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash license fee expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

1,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash accrued interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash accrued interest expense, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation expense

-

-

-

-

-

10

17

23

27

30

31

32

31

31

30

29

25

20

14

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium and accretion of discount on marketable securities, net

673

1,103

1,623

2,091

2,200

1,935

1,486

966

516

260

63

-29

-45

-129

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, related party

-164

-210

-201

-135

-78

8

23

-74

-84

-79

-52

18

-65

-135

-118

-86

58

400

379

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

2,713

1,085

-287

-427

-313

457

1,294

760

411

196

23

142

-69

32

199

224

496

650

686

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

-225

117

399

783

523

504

743

518

468

593

634

820

1,014

652

0

0

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

530

856

2,631

1,178

2,611

5,116

3,416

4,368

4,580

3,052

1,670

851

480

471

225

548

1,625

2,812

3,394

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

-4

0

-0

-1

-1

-6

0

1

1

0

0

0

0

0

0

Accounts payable and accrued expenses, related party

-

-

-

-

-

-

0

0

-95

-

-746

-657

-767

-167

31

-58

134

803

1,058

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

253

210

193

192

192

234

220

221

129

218

0

0

0

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,290

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

10

7

-5

-1

0

0

2

-1

-1

-2

0

0

0

0

0

Increase in accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

6

6

6

5

5

5

5

4

4

4

3

3

0

0

0

Increase in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

0

0

5

0

1

1

0

0

-0

-0

-2

0

0

0

0

Net cash used in operating activities

-60,331

-54,760

-51,038

-51,894

-50,055

-48,655

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-15

-7

-13

-21

-23

-20

-15

-20

-24

-25

-24

-25

-22

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-26,657

-25,349

-24,216

-23,174

-21,116

-17,925

-13,169

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investing Activities
Maturities and sales of marketable securities

153,836

181,246

204,356

203,706

178,306

158,143

136,833

121,883

103,633

77,217

84,827

79,132

76,482

68,605

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

187,997

227,571

230,806

232,465

212,084

237,443

224,842

188,125

166,299

100,635

94,474

52,342

62,967

56,427

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

77

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-34,672

-46,325

-26,450

-28,759

-33,778

-79,300

-88,009

-66,242

-62,666

-23,418

-9,647

26,790

13,515

12,178

-37,950

-41,984

-62,419

-70,626

-30,206

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing Activities
Payments on notes payable, stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from issuances of common stock, net

-

-

-

-

-

132,172

0

0

0

-

-

-

-

-

-

-

-

97,870

47,586

47,841

51,580

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from exercise of stock options

0

-

-

-

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

710

2,710

2,725

2,725

2,015

15

0

25

25

25

25

0

25

25

25

25

0

0

0

0

Proceeds from issuance of restricted stock awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

102,870

54,590

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

111,246

111,101

111,662

185,075

75,093

132,641

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

15

15

0

25

25

25

25

0

25

25

25

25

0

0

0

0

Net increase in cash, cash equivalents and restricted cash

16,243

10,016

34,174

104,422

-8,740

4,686

-2,768

5,504

15,876

1,708

16,553

42

-5,684

-5,718

-4,432

-7,676

-37,245

14,319

11,215

19,801

53,583

1,135

7

-13

3

1

4

9

-20

0

-0

0

-0

-22

0

0

0

Supplemental non-cash disclosures:
Conversion of convertible notes and related accrued interest to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,327

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible notes and related accrued interest to common stock, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,288

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-